LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕
    13/02/2026
    13/02/2026

    The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies

    Do you like it?
    Read more
    06/02/2026
    06/02/2026

    OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States

    Do you like it?
    Read more
    03/02/2026
    03/02/2026

    Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe

    Do you like it?
    Read more
    29/01/2026
    29/01/2026

    EuropaBio Consultation Response: Public Procurement Directives

    Do you like it?
    Read more
    16/12/2025
    16/12/2025

    Higher ambition for EU Biotech

    Do you like it?
    Read more
    11/12/2025
    11/12/2025

    Progress for biotech innovation in General Pharmaceutical Legislation – maximise with the Biotech Act

    Do you like it?
    Read more
    03/12/2025
    03/12/2025

    OECD: Boosting biotechnology innovation through agile regulation and finance instruments

    Do you like it?
    Read more
    14/11/2025
    14/11/2025

    Vial joins EuropaBio: Reimagining Drug Development with Hyper-Scalable Biotech

    Do you like it?
    Read more
    12/11/2025
    12/11/2025

    EuropaBio response to the EU Biotech Act public consultation

    Do you like it?
    Read more
    31/10/2025
    31/10/2025

    Healthcare Associations warn of risks from PFAS restriction approach  – failure to assess the impact on the availability of human and animal medicines

    Do you like it?
    Read more
    14/07/2025
    14/07/2025

    EuropaBio Annual Report 2025

    Do you like it?
    Read more
    11/07/2025
    11/07/2025

    Industrial Decarbonisation Accelerator Act – EuropaBio Position

    Do you like it?
    Read more
    07/07/2025
    07/07/2025

    EuropaBio Position on the Critical Medicines Act

    Do you like it?
    Read more
    03/07/2025
    03/07/2025

    Life Sciences Strategy Embraces Biotech for Global Impact

    Do you like it?
    Read more
    26/06/2025
    26/06/2025

    Health Biomanufacturing: Feedstock for Preparedness and Resilience

    Do you like it?
    Read more
    18/06/2025
    18/06/2025

    EuropaBio conclusions on Patient BioForum 2025

    “EuropaBio is pleased to see this first step in the modernisation of the GM framework and calls for an extension into micro-organisms”
    Do you like it?
    Read more
    10/06/2025
    10/06/2025

    EuropaBio Position on the EU Biotech Act: Prosperity, resilience and leadership for the European Union

    Do you like it?
    Read more
    10/06/2025
    10/06/2025

    The EU economic and scientific future starts with the EU Biotech Act

    Do you like it?
    Read more
    05/06/2025
    05/06/2025

    The GPL must include biotech & life science to unleash EU innovation

    Do you like it?
    Read more
    04/06/2025
    04/06/2025

    EuropaBio response to EC Call for evidence for an evaluation of “Apply AI Strategy – strengthening the AI continent”

    Do you like it?
    Read more
    Load more
    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.